Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites

Journal of Medicinal Chemistry
Alessandro BalianiIan H Gilbert

Abstract

The parasites that give rise to human African trypanosomiasis (HAT) are auxotrophs for various nutrients from the human host, including purines. They have specialist nucleoside transporters to import these metabolites. In addition to uptake of purine nucleobases and purine nucleosides, one of these transporters, the P2 transporter, can carry melamine derivatives; these derivatives are not substrates for the corresponding mammalian transporters. In this paper, we report the coupling of the melamine moiety to selected nitro heterocycles with the aim of selectively delivering these compounds to the parasites. Some compounds prepared have similar in vitro trypanocidal activities as melarsoprol, the principal drug used against late-stage HAT, with 50% growth inhibitory concentrations in the submicromolar range. Selected compounds were also evaluated in vivo in rodent models infected with Trypanosoma brucei brucei and T. brucei rhodesiense and showed pronounced activity and in two cases were curative without overt signs of toxicity. Compounds were also tested against other trypanosomatid pathogens, Leishmania donovani and Trypanosoma cruzi, and significant activity in vitro was noted for T. cruzi against which various nitro heterocyc...Continue Reading

References

Oct 1, 1979·Archives of Biochemistry and Biophysics·R Docampo, A O Stoppani
May 1, 1983·Mutation Research·R Nagel, I Nepomnaschy
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·L J Marton, A E Pegg
May 14, 1999·Parasitology Today·M P Barrett, A H Fairlamb
Oct 8, 1999·Lancet·B L Herwaldt
Feb 25, 2000·Biochemical Pharmacology·M P BarrettJ Perié
Aug 24, 2000·Chemical Research in Toxicology·V Purohit, A K Basu
Apr 27, 2001·Trends in Parasitology·S MüllerR D Walter
Feb 28, 2002·Current Pharmaceutical Design·Simon L Croft, Vanessa Yardley
Jul 20, 2002·The Lancet Infectious Diseases·Dominique LegrosPhilippe Büscher
Nov 14, 2002·Biochemical Pharmacology·Paola PoliTânia Maria Araújo Domingues Zucchi
Sep 25, 2003·Antimicrobial Agents and Chemotherapy·Bertin EnangaMichael P Barrett
Oct 14, 2003·Eukaryotic Cell·Enock MatovuHarry P de Koning
Nov 7, 2003·Lancet·Michael P BarrettSanjeev Krishna
Apr 13, 2004·Eukaryotic Cell·Scott M LandfearMarco A Sanchez
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Mhairi L StewartMichael P Barrett

❮ Previous
Next ❯

Citations

Jun 20, 2012·Future Medicinal Chemistry·Rahul V PatelKishor H Chikhalia
Oct 23, 2013·Future Medicinal Chemistry·Maria V PapadopoulouAna Rodriguez
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Mhairi L StewartMichael P Barrett
Mar 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shane R WilkinsonIan Cheeseman
Oct 8, 2009·The Journal of Biological Chemistry·Catharine J CollarHarry P de Koning
Dec 24, 2009·Antimicrobial Agents and Chemotherapy·Belinda S HallShane R Wilkinson
Nov 9, 2010·The Journal of Pharmacology and Experimental Therapeutics·Sinthujah JeganathanSarah A Thomas
Oct 26, 2011·Journal of Medicinal Chemistry·Maria V PapadopoulouEls Torreele
Oct 30, 2009·Expert Reviews in Molecular Medicine·Shane R Wilkinson, John M Kelly
Jun 12, 2010·Trends in Parasitology·Jean-Claude DujardinGerald F Späth
Jul 10, 2007·British Journal of Pharmacology·M P BarrettR R Tidwell
May 29, 2012·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Aline Pinheiro de MoraesTatiana Pereira-Cenci
Jun 7, 2013·Medicinal Research Reviews·Ling ZhangCheng-He Zhou
Feb 18, 2015·Molecular Microbiology·James A SullivanShane R Wilkinson
Jun 11, 2011·Journal of Enzyme Inhibition and Medicinal Chemistry·Prashant Gahtori, Surajit K Ghosh
Sep 23, 2014·European Journal of Medicinal Chemistry·Maria V PapadopoulouMarcel Kaiser
Sep 26, 2014·PloS One·Federica PratiMaria Laura Bolognesi
Dec 1, 2006·Advances in Parasitology·Michael P Barrett, Ian H Gilbert
Dec 17, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Qiang YuPer Carlsen
Sep 8, 2018·Journal of Labelled Compounds & Radiopharmaceuticals·Mohamed A MotalebWafaa A Zaghary
Aug 31, 2006·Current Opinion in Infectious Diseases·Reto Brun, Oliver Balmer
Mar 6, 2009·Organic & Biomolecular Chemistry·Alessandro BalianiIan H Gilbert
Sep 17, 2010·Current Opinion in Infectious Diseases·Michael P Barrett
Oct 24, 2013·Chemistry, an Asian Journal·Qinghua ZhangJean'ne M Shreeve
Mar 25, 2015·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Hyun Seung Ban, Hiroyuki Nakamura
Oct 10, 2009·Journal of Enzyme Inhibition and Medicinal Chemistry·Dharmendra H PatelVipul M Buha
Jul 14, 2018·Acta Crystallographica. Section E, Crystallographic Communications·Ramalingam SangeethaSavaridasson Jose Kavitha
Jan 23, 2020·Tropical Medicine and Infectious Disease·Harry P De Koning
Sep 25, 2018·Bioinorganic Chemistry and Applications·Supun KatugampalaTheshini Perera
Jun 7, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Mingxing WangQilong Lu
Jan 27, 2011·Chemistry : a European Journal·Yangen HuangJean'ne M Shreeve
Nov 2, 2019·European Journal of Medicinal Chemistry·Hao LiuGao-Feng Zha
Jan 6, 2010·Journal of Medicinal Chemistry·Boulos ZacharieChristopher L Penney
Oct 24, 2007·Journal of Medicinal Chemistry·Svetlana M BakunovaRichard R Tidwell
Jun 3, 2021·International Journal of Molecular Sciences·Tam Minh LeZsolt Szakonyi
May 4, 2012·Journal of Medicinal Chemistry·Maria V PapadopoulouJean-Robert Ioset
Nov 23, 2021·Chemistry, an Asian Journal·Leonid V RomashovValentine P Ananikov

❮ Previous
Next ❯

Related Concepts

Related Feeds

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.